<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Thrombomodulin is expressed at the surface of endothelial cells and controls thrombin generation and thrombin-induced platelets and vascular cell activation </plain></SENT>
<SENT sid="1" pm="."><plain>Several thrombomodulin gene polymorphisms have been associated with coronary events and <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In a previous analysis from the Etude <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">du</z:e> Profil Génétique de l'Infarctus Cérébral (GENIC) study, we found that soluble thrombomodulin (sTM) concentration modulated the risk of and prognosis for <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In 474 brain infarction cases and 483 controls from the GENIC study, we investigated the relationship between three thrombomodulin gene polymorphisms (-1748G/C, -1208/-1209delTT, +1418C/T) and sTM levels, <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> risk and 5-year mortality after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The three polymorphisms were in linkage disequilibrium and defined three major haplotypes with no influence on sTM concentration (<z:hpo ids='HP_0000001'>all</z:hpo> P values &gt; 0.16) </plain></SENT>
<SENT sid="5" pm="."><plain>Single locus and haplotype analyses found no significant association with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, even when the analysis was restricted to individuals without a vascular history </plain></SENT>
<SENT sid="6" pm="."><plain>After 5 years of follow-up, we found no relationship with vascular or total mortality (<z:hpo ids='HP_0000001'>all</z:hpo> P values &gt; 0.64) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our results suggest that these three thrombomodulin gene polymorphisms do not contribute to sTM level variations and are not associated with risk of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and mortality after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>